NCT00799084
- Conditions
- Carcinoma, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
- Michigan State University East Lansing, Michigan, United States
Clinical trial condition
Carcinoma
Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.
518 public trials
102 recruiting studies
Carcinoma trial results
Completed
Pain and Fatigue Study
NCT00006253
- Conditions
- Carcinoma, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
- Michigan State University East Lansing, Michigan, United States
NCT00191308
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bystra, Poland
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland
NCT00332696
- Conditions
- Abdominal Neoplasms, Carcinoma, Carcinomatosis, +11 more
- Locations
-
- Novartis Investigative Site Créteil, France
NCT00960557
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- OXiGENE Investigational Site Westmead, New South Wales, Australia
- OXiGENE Investigational Site South Brisbane, Queensland, Australia
- OXiGENE Investigational Site Adelaide, South Australia, Australia
- OXiGENE Investigational Site Bentleigh, Victoria, Australia
NCT00073736
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- University of California at Irvine Orange, California, United States
- Prince of Wales Hospital - Comprehensive Cancer Trial Unit Shatin, New Territories, Hong Kong
- Tri-Services General Hospital Taipei, Nei Hu District, Taiwan
- Chang-Gung Memorial Hospital Taipei, Taoyuan County, Taiwan
NCT00466583
- Conditions
- Carcinoma, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- Joe Arrington Cancer Research and Treatment Center Lubbock, Texas, United States
NCT00031278
- Conditions
- Carcinoma, Carcinoma, Metastatic Breast, Neoplasm Metastasis, +6 more
- Locations
-
- Univ. of Connecticut Health Center Farmington, Connecticut, United States
- Cancer Research Network, Inc. Plantation, Florida, United States
- Greenebaum Cancer Center at Univ. of Maryland Baltimore, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00616135
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +12 more
- Locations
-
- Jules Bordet Institute of Cancer Brussels, Belgium
- Università degli Studi di Firenze Florence, Italy
- Hospital General Universitario Gregorio Marañon Madrid, Spain
- Instituto Valenciano Oncologia Valencia, Spain
NCT00879554
- Conditions
- Advanced Solid Tumors, Cancer, Carcinoma, +4 more
- Locations
-
- Pfizer Investigational Site Scottsdale, Arizona, United States
- Pfizer Investigational Site Santa Monica, California, United States
- Pfizer Investigational Site Philadelphia, Pennsylvania, United States